Cercar

17/05/2024 Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study
Jiménez, A, Vlacho, B, Mata-Cases, M, Real, J, Mauricio, D, Franch-Nadal, J, Ortega, E. Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1344007. PMID:38828412. IF:4.600(Q1/3D).
07/05/2024 Effects of Bariatric Surgery on HDL Cholesterol (vol 30, pg 1793, 2020)
Genua, I, Ramos, A, Caimari, F, Balagué, C, Sánchez-Quesada, JL, Pérez, A, Miñambres, I. Effects of Bariatric Surgery on HDL Cholesterol (vol 30, pg 1793, 2020). OBESITY SURGERY. 2024; 34(6)DOI:10.1007/s11695-024-07263-9. PMID:38710974. IF:3.100(Q1/2D).
01/05/2024 Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities-based post hoc analysis of the OneCare study
Gomez-Peralta, F, Ballesteros, AC, Martínez, AM, Corral, BP, Donlo, IC, Melo, PF, Arnáez, FZ, Rodríguez, MM. Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities-based post hoc analysis of the OneCare study. DIABETES OBESITY & METABOLISM. 2024; 26(5)DOI:10.1111/dom.15496. PMID:38379106. IF:5.700(Q1/2D).
01/05/2024 A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response
Beato-Vibora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Gimenez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mira, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response. DIABETES CARE. 2024; 47(5)DOI:10.2337/dci24-0017. PMID:38640410. IF:16.600(Q1/1D).